Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Adimmune Corp (4142) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7948
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provides therapeutic nucleic acids, influenza vaccine, entrovirus 71 vaccine, and Japanese encephalitis vaccine. Adimmune offers such as seasonal flu vaccine plant, testing and analysis services, fill and finish services, quality assurance courses, and consulting services. The corporation offers product testing and analysis of quality of vaccines and biological products, and also offers other relevant testing services. It sells products through a network of distributors in Taiwan. Adimmune is headquartered in Taichung, Taiwan.

Adimmune Corp (4142) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Adimmune Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Licensing Agreements 11
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Debt Offering 13
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp – Key Competitors 14
Adimmune Corp – Key Employees 15
Adimmune Corp – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Adimmune Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp, Key Competitors 14
Adimmune Corp, Key Employees 15

List of Figures
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banyan Tree Holdings Ltd:戦略・SWOT・企業財務分析
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Caspian Energy Inc. (CKZ.H)-石油・ガス分野:企業M&A・提携分析
    Summary Caspian Energy Inc. (Caspian) is an independent upstream oil and gas company that explores for and develops hydrocarbon reserves, and produces oil and gas. Caspian and its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license which entitles it to explore …
  • Mckesson Europe AG.:企業の戦略・SWOT・財務情報
    Mckesson Europe AG. - Strategy, SWOT and Corporate Finance Report Summary Mckesson Europe AG. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ConMed Corporation (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corporation (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Technip SA (TEC)-石油・ガス分野:企業M&A・提携分析
    Summary Technip SA (Technip) is a provider of project management, engineering and construction services to energy sector. It offers a comprehensive portfolio of technologies and services for the subsea oil and gas developments to the largest and most complex offshore and onshore infrastructures. The …
  • Oramed Pharmaceuticals Inc (ORMP)-製薬・医療分野:企業M&A・提携分析
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • PixCell Medical Technologies Ltd:企業の製品パイプライン分析
    Summary PixCell Medical Technologies Ltd (PixCell) is a medical device company that develops, produces and markets portable medical diagnostic products for point of care testing. The company’s product comprises hemoscreen, a portable hematology analyzer used for blood sampling and analysis. Its hemo …
  • Vietnam Joint Stock Commercial Bank for Industry and Trade:企業の戦略・SWOT・財務情報
    Vietnam Joint Stock Commercial Bank for Industry and Trade - Strategy, SWOT and Corporate Finance Report Summary Vietnam Joint Stock Commercial Bank for Industry and Trade - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the …
  • Europ Assistance Holding SA:企業の戦略的SWOT分析
    Europ Assistance Holding SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Drive Shack Inc:企業のM&A・事業提携・投資動向
    Drive Shack Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Drive Shack Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • ChemAxon Kft:医療機器:M&Aディール及び事業提携情報
    Summary ChemAxon Kft (ChemAxon) is a provider of software platforms. The company provides chemistry and biology software solutions and consultancy services that help in optimizing the value of chemistry information in life sciences and research and development. Its product portfolio consists of desk …
  • Emmaus Life Sciences Inc (EMMA):企業の財務・戦略的SWOT分析
    Emmaus Life Sciences Inc (EMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bankinter, S.A.:企業の戦略・SWOT・財務情報
    Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report Summary Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Gilbane Inc:企業の戦略・SWOT・財務情報
    Gilbane Inc - Strategy, SWOT and Corporate Finance Report Summary Gilbane Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Eiger BioPharmaceuticals Inc (EIGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Highmark Inc.:企業の戦略・SWOT・財務分析
    Highmark Inc. - Strategy, SWOT and Corporate Finance Report Summary Highmark Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bangladesh Power Development Board-エネルギー分野:企業M&A・提携分析
    Summary Bangladesh Power Development Board (BPDB) is an integrated energy statutory board. It generates electricity through owned power plants and procures electricity from public and private generation companies. The board utilizes gas, coal, hydro, furnace oil, and diesel as fuel source for electr …
  • Finance Wales plc:企業のM&A・事業提携・投資動向
    Finance Wales plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finance Wales plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆